282 related articles for article (PubMed ID: 26093347)
21. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy and photobiomodulation therapy in zoledronic acid-induced osteonecrosis in rats.
Silva PGB; Praxedes Neto RALP; Lima LA; Lemos JVM; Rodrigues MIQ; Alves APNN; Dantas TS; Lima RA
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102889. PubMed ID: 35489689
[TBL] [Abstract][Full Text] [Related]
23. Bacterial profile and bone healing in rats receiving cancer therapeutic doses of bisphosphonates and corticosteroids: a pilot study.
Jabbour Z; do Nascimento C; El-Hakim M; Henderson JE; de Albuquerque Junior RF
Int J Oral Maxillofac Surg; 2016 Sep; 45(9):1162-9. PubMed ID: 26780925
[TBL] [Abstract][Full Text] [Related]
24. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
25. Nitrogen-containing bisphosphonate therapy: assessment of the alveolar bone structure in rats - a blind randomized controlled trial.
Pacheco VN; Langie R; Etges A; Ponzoni D; Puricelli E
Int J Exp Pathol; 2015 Aug; 96(4):255-60. PubMed ID: 26119047
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
[TBL] [Abstract][Full Text] [Related]
27. Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation.
Yanık S; Aras MH; Erkılıç S; Bozdağ Z; Demir T; Çetiner S
Arch Oral Biol; 2016 May; 65():59-65. PubMed ID: 26854621
[TBL] [Abstract][Full Text] [Related]
28. Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis.
Lima-Verde MEQ; de Queiroz Rodrigues MI; Vieira BR; Lima-Verde Neto FTG; Agressott EVH; de Sousa FB; Paschoal AR; de Barros Silva PG; Sousa FB; Mota MRL; Alves APNN
J Bone Miner Metab; 2023 Nov; 41(6):760-771. PubMed ID: 37673837
[TBL] [Abstract][Full Text] [Related]
29. Experimental model of osteonecrosis of the jaw in rats treated with zoledronic acid.
Kolpakova ME; Zubarevа AA; Artamonova TD; Lisovskaya EK; Chefu SG; Yagmurov OD; Yaremenko AI; Vlasov TD
Br J Oral Maxillofac Surg; 2017 Feb; 55(2):156-159. PubMed ID: 27780611
[TBL] [Abstract][Full Text] [Related]
30. The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice.
Yu W; Su J
Oral Dis; 2020 Apr; 26(3):609-620. PubMed ID: 31903673
[TBL] [Abstract][Full Text] [Related]
31. Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats.
Nakagawa T; Tsuka S; Aonuma F; Nodai T; Munemasa T; Tamura A; Mukaibo T; Kondo Y; Masaki C; Hosokawa R
J Prosthodont Res; 2021 Jun; 65(2):219-224. PubMed ID: 32938854
[TBL] [Abstract][Full Text] [Related]
32. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
33. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
[TBL] [Abstract][Full Text] [Related]
34. Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats.
Dayisoylu EH; Üngör C; Tosun E; Ersöz S; Kadioglu Duman M; Taskesen F; Senel FÇ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):329-34. PubMed ID: 24368141
[TBL] [Abstract][Full Text] [Related]
35. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
36.
Wu S; Li F; Tan J; Ye X; Le Y; Liu N; Everts V; Wan Q
Front Cell Infect Microbiol; 2022; 12():886411. PubMed ID: 35811676
[TBL] [Abstract][Full Text] [Related]
37. A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.
Howie RN; Borke JL; Kurago Z; Daoudi A; Cray J; Zakhary IE; Brown TL; Raley JN; Tran LT; Messer R; Medani F; Elsalanty ME
PLoS One; 2015; 10(7):e0132520. PubMed ID: 26186665
[TBL] [Abstract][Full Text] [Related]
38. Zoledronic acid aggravates kidney damage during ischemia reperfusion injury in rat.
Sehitoglu I; Tumkaya L; Bedir R; Kalkan Y; Cure MC; Yucel AF; Zorba OU; Yuce S; Cure E
J Environ Pathol Toxicol Oncol; 2015; 34(1):53-61. PubMed ID: 25746831
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
[TBL] [Abstract][Full Text] [Related]
40. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
